Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[EX Q]: Paragraph: That— and some TLC — usually does the job. At a recent meeting, the Janesville School Board received the annual school nursing report. The report showed that while Band-Aids and ice packs are applied by the hundreds, school nurses are dealing with more serious concerns. Between the 2014-15 school year and the 2018-19 school year, the number of students requiring health plans, daily medication, inhalers and emergency medication has slowly crept up. Nurses, with the help of health aides, hand out daily medication; set up medical kits for field trips; work with doctors, nurses and parents to serve students with medically complex needs; give eye exams; and provide education and support to parents on everything from bed bugs to seizures and toilet training to allergies, The Janesville Gazette reported. That’s the short list. By the numbers In the 2018-19 school year, the Janesville School District had five nurses serving 10,049 students at 21 district schools and 13 private or nonprofit four-year-old kindergartens. That’s a ratio of one nurse to 2,010 students. Student numbers will remain about the same for the 2019-20 school year. “While the Department of Public Instruction does not mandate a specific ratio to school districts, the average ratio of school nurses to pupils in Wisconsin school districts is 1 to 1,625,” district Director of Pupil Services Kimberli Peerenboom wrote in her report to the board. State law does not require schools to have nurses but does say “emergency nursing services shall be available during the regular school day and during all school sponsored activities of students.” Along with the five nurses, the district also uses health aides. Each elementary school has four hours a day the principal can designate as health aide hours, according to Peerenboom’s report. In the upper grades, principals don’t have hours to designate, but they can assign health-aide duties to office staff, the report stated. Some health aides are also secretaries or serve in other paraprofessional roles that involve working with students. Apart from the general cuts and scrapes, 1,715 students had a documented health condition. Asthma, allergies and attention deficit disorder make up the majority of those cases. Other conditions include Crohn’s disease, diabetes, migraines, cerebral palsy, depression, anxiety and autism spectrum disorders. In addition, 227 students take a daily medication at school, that’s up from 183 students in the 2016-17 school year. The number of students who need emergency medication has gone from 134 students in the 2014-15 school year to 231 in the 2018-19 school year. Nurses aren’t in charge of figuring out why those numbers have increased, they just have to deal with the results. In the 2018-19 school year, nurses and health aides reported 161,089 visits from students, according to Peerenboom’s report. A visit counted as anything from needing a Band-Aid to taking daily medication, the report said. With 21 schools, that’s an estimated 43 visits per day. The numbers in action Based on a recent morning spent with school nurse Heidi Bakke, 43 students a day seemed like a reliable count. An hour before the 8:20 a.m. bell at Wilson Elementary, Bakke was updating a health plan. Such plans are for students with chronic conditions who might need monitoring or intervention during the school day. Creating a plan involves a complex back and forth among the school nurse, parents, and physicians and their nurses. It can be a complicated process. ″(The nurses) are probably not going to be in the building when the emergency happens, so we train medical emergency response teams at each school,” Bakke said. The nursing team recently implemented “grab-and-go bags.” The bags contain all the emergency supplies for children with medical needs and a copy of each child’s health plan. Nurses also must prepare a similar kit when a student with a health plan goes on a field trip. And the nurses also have to let teachers know what to look for. “The kiddos who have diabetes — those are the hardest ones to train teachers on because they have frequent blood sugar checks.” Bakke said. “If the kid is out hiking at the Janesville Schools Outdoor Lab, their blood sugar might drop, so you have to have snacks available.” The morning we visited, Bakke was mentoring a new nurse, Holly Cavey. Also in the small office was Cheri Diehls, the school’s part-time health aide. Once Cavey is trained, she will have five schools to cover, while Bakke has six. That’s another change. Nurses used to travel to all schools, now they’re assigned to five or six. “It’s a better model,” Bakke said. “It provides better continuity of care. I want the kids to get to know nurse Heidi.” While the nurses worked on reports, responded to emails and took calls from physicians’ offices and parents, kids needing immediate attention trooped in and out of the office. There were general owies, issues with hearing or sight, a bloody nose, a student needing their daily medication, another needing help with an inhaler, and a half dozen other issues traditionally associated with a trip to the nurse’s office. Cavey and Bakke then headed to Franklin Middle School, where there seemed to be a lunch rush in the nurse’s office. Health aide Angela Basurto-Bonilla was keeping things calm, explaining to students that if their temperature was normal and they weren’t throwing up, it would be best for them to stay in school. The nurse’s office is across from the main office, and sometimes the new students got them mixed up. The proximity works well since sometimes the office secretaries worked as health aides. “Do you feel sick? Well, you’re in the right place,” Basurto-Bonilla told a student. Bakke said the health aides were crucial to the success of the district’s nursing program. Their skills, demeanor and their day-to-day knowledge of students are crucial to the nurse’s work. Despite the number of reports she writes and the amount of training she does, it’s the interaction with students that’s the most important to her. ___ Information from: The Janesville Gazette, http://www.gazetteextra.com Claim: School nurses serve many needs.
[EX A]: School injuries usually don’t require much care: a Band-Aid for a scraped knee, an ice pack for a bump or bruise, or a tissue for a bloody nose.

[EX Q]: Paragraph: “I could not go to the DRC (Congo) without coming to meet the brave inhabitants of this beautiful territory,” U.N. chief Antonio Guterres said. “There are major concerns about health. There is measles, malaria, cholera and now the terrible drama of Ebola. We are fully on the side of the Congolese people to try to meet all these challenges.” Guterres also pledged the U.N. peacekeeping forces’ support with the armed forces of Congo in the fight against extremism “that is threatening not only Congo but Africa and the world.” He is on a three-day trip to Congo. He stopped in Goma earlier and on Monday will meet with Congo’s President Felix Tshisekedi. “It is important for the people of Beni to know that we have heard their cries of distress. The United Nations as a whole is committed to supporting the Congolese authorities, local communities and civil society actors in the fight against insecurity,” he said while in Beni, adding that he will discuss these issues when he visits Kinshasa on Monday. Guterres’ trip comes as Ebola cases are about the topple 3,000 along with nearly 2,000 deaths in eastern Congo since the outbreak was declared a year ago. Health authorities have faced major challenges trying to stem the spread of the disease amid insecurity and mistrust from communities. Traumatized by Ugandan Allied Democratic Forces rebels since October 2014, residents of Beni say they do not trust the U.N. peacekeepers, who they say have done little to protect them from rebel attacks. The region is home to numerous rebel groups vying for control of the mineral-rich land. “Imagine rebels attacking in the evening but we try to call MONUSCO but they arrive in the morning with cameras,” said Nzanu Nzoli a former resident of the town of Eringeti who traveled to Beni to flee the attacks. “The visit of Antonio Guterres will not change the current state of our situation in Beni because before him we had already received the promises of the Congolese government and the U.N. ... But it will soon be five years without action. ... Nothing will change.” Others in the area said a visit from the head of the U.N. could boost military operations. “I believe that with his visit ... Antonio Guterres will learn about the current situation of the rebels, and the evolution of Ebola. Often he receives reports but he will feel the situation, so I hope for a favorable outcome,” said Kambale Mundoleko, an Ebola survivor near Beni in Mangina who lost her entire family. Upon his arrival in Mangina, Guterres visited an Ebola treatment center and also witnessed the unloading of four Ebola patients. Claim: UN chief visits Congo Ebola region, pledging support.
[EX A]: The United Nations secretary general visited Congo’s eastern city of Beni on Sunday, pledging solidarity as the region faces an Ebola outbreak that has killed nearly 2,000 people in a year and ongoing insecurity that has residents skeptical of outside help.

[EX Q]: Paragraph: The European Medicine Agency (EMA) also backed a new drug from Dainippon Sumitomo Pharma called Latuda, for the treatment of schizophrenia, and Bemfola, a new biosimilar medicine for the treatment of infertility. But the regulator decided against recommending Teva’s new multiple sclerosis (MS) pill Nerventra, or laquinimod, which the Israeli firm is developing with Swedish partner Active Biotech, and recommended rejecting an application from Swiss drugmaker Novartis to market its heart failure drug serelaxin. Recommendations for marketing approval by the EMA’s Committee for Medicinal Products for Human Use (CHMP) are normally endorsed by the European Commission within a couple of months. The prospects for laquinimod were already viewed by analysts as uncertain, since the drug missed its main goal in a late-stage trial in 2011 and U.S. regulators have asked for another Phase III study before considering it. Analysts at Jefferies in London said the rejection of Teva’s MS drug was as they had expected and was driven by three major concerns - about the possible link to risk of cancers and pregnancy dangers, and its modest effect on relapse rates which suggested an unfavorable risk-benefit balance for the drug. On Bayer’s Adempas, the EMA said the key benefits of the drug were “its ability to provide significant improvement in exercise capacity and pulmonary haemodynamics in two specific conditions known as chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.”  Adempas, which belongs to a class of drugs known as soluble guanylate cyclase stimulators that help arteries relax to increase blood flow and decrease blood pressure, got backing from drugs regulators in United States in October last year, and in Japan earlier this month. The EMA also issued negative opinions for two so-called orphan medicines - Masiviera from France’s AB Science, intended for certain types of advanced pancreatic cancer, and Translarna, from PTC Therapeutics, designed to treat Duchenne muscular dystrophy. GSK’s once-weekly diabetes drug albiglutide won the EMA’s recommendation and will be sold under the brand name Eperzan. It belongs to the same class of injectable GLP-1 drugs as Victoza, from Novo Nordisk, as well as Byetta and Bydureon, from Bristol-Myers Squibb and AstraZeneca. Last year regulators in the United States pushed back an approval decision on the drug until April 15. Claim: EU regulator backs Bayer, GSK drugs, knocks back Novartis, Teva.
[EX A]:
Europe’s drugs regulator gave its backing on Friday for marketing approval to be granted for Bayer’s pulmonary hypertension drug Adempas and for GlaxoSmithKline’s diabetes medicine Eperzan.